These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy]. Citarrella P; Abbadessa V; Pecorella M; Cajozzo A Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239 [No Abstract] [Full Text] [Related]
7. [Double-blind clinical trial of a new coronary-active drug, MD 6753]. Dalla Volta S Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049 [No Abstract] [Full Text] [Related]
8. The use of urokinase, pyridinolcarbamate, and dypiridamole in rat heart allografts. Ono K; Hattori T; Inokuchi K Surgery; 1973 Jan; 73(1):128-32. PubMed ID: 4566777 [No Abstract] [Full Text] [Related]
9. [Effect of pyridinolcarbamate on blood coagulation and thrombolysis in patients with arteriosclerosis obliterans]. Hess H; Goossens N; Keil-Kuri E; Zollner R; Meyer A Vasa; 1972; 1(3):206-11. PubMed ID: 5076123 [No Abstract] [Full Text] [Related]
10. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease]. Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850 [No Abstract] [Full Text] [Related]
11. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine]. Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131 [No Abstract] [Full Text] [Related]
12. [Effect of Production on the serum lipid and lipoprotein level in ischemic heart disease]. Orbetsov M; Orbetsova V; Todorova M; Mikhaĭlova M; Atanasova M Vutr Boles; 1977; 16(6):16-22. PubMed ID: 203118 [TBL] [Abstract][Full Text] [Related]
13. A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion. Mishima Y; Kamiya K; Sakaguchi S; Kusaba A; Sakuma A Angiology; 1977 Feb; 28(2):84-94. PubMed ID: 326097 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and electrocardiographic evaluation of the effects of nifedipine in ischemic cardiopathy with the stenocardiac syndrome]. Mastrocola C; Baratta L; Tubani L; Vittori G; Petrosillo N; Avella A Boll Soc Ital Cardiol; 1978; 23(10):1721-5. PubMed ID: 122222 [No Abstract] [Full Text] [Related]
15. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography. Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577 [No Abstract] [Full Text] [Related]
16. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic]. Gel'fgat EB; Muradova SA; Iagizarova NM; Abdullaeva IA Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the effects of nifedipine and nitroglycerin on the asynergic areas in chronic ischemic cardiopathy]. Rizzon P; Franchini G; Chiddo A Boll Soc Ital Cardiol; 1978; (1 Suppl):98-104. PubMed ID: 120202 [No Abstract] [Full Text] [Related]
18. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients]. Valiensi M; Riboli E; Lombardi M Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654 [No Abstract] [Full Text] [Related]
19. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood. Nelemans FA Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745 [No Abstract] [Full Text] [Related]